This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Liquorice

Authoring team

This has been shown to inhibit the enzyme in the kidney that lowers the plasma cortisol (by conversion to cortisone which thus maintains mineralocorticoid receptors free for aldosterone). Thus liquorice ingestion can lead to lead to an excess mineralocorticoid action and effects similar to that of hyperaldosteronism e.g. hypokalaemia.

Diagnosis of overconsumption

  • liquorice overconsumption should be suspected clinically in patients presenting with otherwise unexplained hypokalemia and muscle weakness
    • a clue is provided when dietary history reveals excessive liquorice intake - note that liquorice is contained in some herbal medicines (2)
    • due to its aldosterone-like action, laboratory investigations reveal hypokalemia and metabolic alkalosis
      • creatine phosphokinase (CPK) may be elevated in cases with rhabdomyolysis (due to severe hypokalemia) which may be complicated with acute tubular necrosis
  • the inhibition of 11-ß-hydroxysteroid dehydrogenase by liquorice will cause reduction in the conversion of cortisol to cortisone
    • therefore, in conditions causing pseudo-hyperaldosteronism (as licorice excess), the cortisol:cortisone ratio in the peripheral venous plasma is sharply raised. Moreover licorice-induced hypertension is also accompanied by reduction in plasma renin as well as aldosterone level, which is not the case in primary or secondary hyperaldosteronism.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.